Clinical Research Directory
Browse clinical research sites, groups, and studies.
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
Sponsor: Columbia University
Summary
To determine the efficacy of a multicomponent adherence intervention among participants with early-stage breast cancer on endocrine therapy and at least one oral cardiovascular disease (CVD) medication on adherence to endocrine therapy and to CVD medication at 24 weeks assessed by self-report using the Domains of Subjective Extent (DOSE)-Nonadherence questionnaire and also by pharmacy fill data assessed in the electronic health record (EHR).
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2023-03-02
Completion Date
2027-03-31
Last Updated
2025-02-12
Healthy Volunteers
No
Conditions
Interventions
Multicomponent Adherence Intervention
The adherence intervention will be comprised of a participant preference approach in which all participants undergo a baseline pharmacist-led medication optimization session and are offered training in how to use the patient portal and freely-available smartphone reminder app.
Usual Care
Receipt of usual care from providers
Locations (1)
Columbia University Medical Center
New York, New York, United States